Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2019 May-Jun:55:65-70.
doi: 10.1016/j.clinimag.2019.01.012. Epub 2019 Jan 31.

Measurement of the liver iron concentration in transfusional iron overload by MRI R2* and by high-transition-temperature superconducting magnetic susceptometry

Sujit Sheth  1 , Christopher J Allen  2 , David E Farrell  3 , John H Tripp  3 , Ramin Jafari  4 , Yi Wang  5 , Gary M Brittenham  6
Affiliations
Comparative Study

Measurement of the liver iron concentration in transfusional iron overload by MRI R2* and by high-transition-temperature superconducting magnetic susceptometry

Sujit Sheth et al. Clin Imaging. 2019 May-Jun.

Abstract

Purpose: To compare measurement of the liver iron concentration in patients with transfusional iron overload by magnetic resonance imaging (MRI), using R2*, and by magnetic susceptometry, using a new high-transitiontemperature (high-Tc; operating at 77 K, cooled by liquid nitrogen) superconducting magnetic susceptometer.

Methods: In 28 patients with transfusional iron overload, 43 measurements of the liver iron concentration were made by both R2* and high-Tc magnetic susceptometry.

Results: Measurements of the liver iron concentration by R2* and high-Tc magnetic susceptometry were significantly correlated when comparing all patients (Pearson's r = 0.91, p < 0.0001) and those with results by susceptometry >7 mg Fe/g liver, dry weight (r = 0.93, p = 0.006). In lower ranges of liver iron, no significant correlations between the two methods were found (0 to <3.2 mg Fe/g liver, dry weight: r = 0.2, p = 0.37; 3.2 to 7 mg Fe/g liver, dry weight: r = 0.41; p = 0.14).

Conclusion: The lack of linear correlation between R2* and magnetic susceptibility measurements of the liver iron concentration with minimal or modest iron overload may be due to the effects of fibrosis and other cellular pathology that interfere with R2* but do not appreciably alter magnetic susceptibility.

Keywords: High-transition-temperature superconductors; Liver iron concentration; MRI; Magnetic susceptometry; R2*; Superconducting transition temperature.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The new high-transition-temperature (high-Tc; operating at 77°K, cooled by liquid nitrogen) superconducting magnetic susceptometer, set up to measure the susceptibility of a solid polyethylene cylinder with respect to water. The principal components of the system are the support bed (front), data acquisition electronics (left rear), susceptometer module, polyethylene cylinder and water bellows (center), and support gantry (center, rear).
Figure 2.
Figure 2.
Relationships between liver iron concentration (LIC) determined by MRI R2* and by high-transition-temperature (high-Tc; operating at 77°K, cooled by liquid nitrogen) magnetic susceptometry (left panels), and Bland-Altman plots of the percent difference between the R2* and susceptometric measurements and their average (right panels). A. All patients. B. Patients with LIC by susceptometry >7 mg Fe/g dry weight C. Patients with LIC by susceptometry >3.2 - 7 mg Fe/g dry weight. D. Patients with LIC by susceptometry 0 to 3.2 mg Fe/g dry weight
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Brittenham GM. Disorders of iron homeostasis: iron deficiency and overload In: Hoffman RBE, Silberstein LE, Heslop H, Weitz JI, Anastasi J, Salama ME, Abutalib SA, editor Hematology: Basic Principles and Practice. New York: Elsevier; 2018, p. 478–90.
    1. Brittenham GM. Iron-chelating therapy for transfusional iron overload. N Engl J Med 2011;364(2):146–56. - PMC - PubMed
    1. Coates TD. Physiology and pathophysiology of iron in hemoglobin-associated diseases. Free radical biology & medicine 2014;72:23–40. - PMC - PubMed
    1. Porter JB, de Witte T, Cappellini MD, Gattermann N. New insights into transfusion-related iron toxicity: Implications for the oncologist. Critical reviews in oncology/hematology 2016;99:261–71. - PubMed
    1. Hoffbrand AV, Taher A, Cappellini MD. How I treat transfusional iron overload. Blood 2012;120(18):3657–69. - PubMed

Publication types